MAIA
MAIA Biotechnology
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- MAIA Biotechnology reaches patient enrollment milestones in ongoing Phase 2 and pivotal Phase 3 trials for non-small cell lung cancerOct 7, 2026
- MAIA Biotechnology expands its pivotal Phase 3 THIO-104 non-small cell lung cancer trial into Spain and PortugalSep 23, 2026
- MAIA Biotechnology reports progress in its pivotal Phase 3 clinical trial for advanced non-small cell lung cancerSep 22, 2026
- MAIA Biotechnology dosed the first U.S. patient in its ongoing Phase 2 trial for non-small cell lung cancerSep 16, 2026
- MAIA Biotechnology reported strong initial efficacy data from the Phase 2 THIO-101 Part C expansion trial in third-line non-small cell lung cancerJul 9, 2026